Today: 17 April 2026
Lumentum stock price drops after hours as investors eye Susquehanna, Morgan Stanley talks
11 February 2026
1 min read

Lumentum stock price drops after hours as investors eye Susquehanna, Morgan Stanley talks

New York, February 10, 2026, 17:43 EST — Trading after the bell.

Lumentum Holdings Inc shares dropped 2.8% to $561.13 in late trading Tuesday, following a volatile day session. The stock hit a peak of $579 and dipped to $531, with volume reaching roughly 4.8 million shares.

This shift carries weight: Lumentum acts as a high-beta proxy for AI-driven data-center construction, where even minor changes in order timing can quickly sway expectations. The stock, still working through a hefty rally, leaves investors wanting more detail on demand trends, supply, and pricing.

This comes right before a run of conference appearances, where management Q&A often carries more weight than any press release. For traders, these sessions double as live gut-checks on whether the growth narrative still holds up—or if it’s starting to run away from reality.

Lumentum said Tuesday its management will join Susquehanna’s 15th Annual Technology Conference on Feb. 26 for meetings, then move on to Morgan Stanley’s Technology, Media & Telecom Conference on March 2. The latter event includes a webcast, with Lumentum set for an 11:30 a.m. Pacific slot.

Last week, the company posted fiscal Q2 revenue of $665.5 million, with adjusted earnings coming in at $1.67 per share. For the third quarter, they’re projecting revenue between $780 million and $830 million, and adjusted EPS ranging from $2.15 to $2.35. CEO Michael Hurlston pointed out that revenue landed at the top end of their target, highlighting strength in optical circuit switches—gear that directs data using light within networks—and co-packaged optics, which bring optics closer to chips to help reduce power use.

During the earnings call, Hurlston described the company as “recognized as a foundational engine of the AI revolution,” a line that’s been pivotal in reframing the stock’s sharp re-rating in the last few sessions. Investing.com

Tuesday saw Coherent drop 5.9% in the optical and AI infrastructure sector. Broadcom gave up 1.0%, and Marvell Technology ticked 0.4% lower.

The setup isn’t one-sided. When everyone’s counting on breakneck growth, even a whiff of weaker demand, supply hiccups, or squeezed margins can hammer the shares—regardless of the bigger-picture thesis holding up.

Next session, eyes will be on whether the stock finds its footing post-pullback and if trading continues to track the broader AI-infrastructure names, instead of being driven by company news.

Eyes now turn to management’s upcoming conference appearances, with Susquehanna hosting meetings on Feb. 26. Then comes the Morgan Stanley webcast—March 2, set for 11:30 a.m. Pacific.

Stock Market Today

  • Axon Enterprise Shares Show Volatility but Fairly Valued on DCF Model
    April 16, 2026, 11:07 PM EDT. Axon Enterprise's stock has swung sharply, with a 29.7% drop over 12 months but a 75.1% gain over three years. The shares trade around $393, near the estimated intrinsic value of $381 from a Discounted Cash Flow (DCF) analysis, which values future free cash flow. This suggests the stock is roughly fairly valued, with a small 3.2% overvaluation margin that is typical for such models. Axon scores low on valuation metrics, reflecting investor caution amid its ongoing growth investments. Market participants should watch these dynamics closely, as DCF intrinsic value and sales-based price multiples offer different perspectives on the company's worth amid share price fluctuations.

Latest article

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

16 April 2026
Hims & Hers Health shares rose to $26.65 Thursday after the FDA said it would reconsider restrictions on several peptides, removing 12 from a high-risk list and scheduling a July review of seven more. The move follows Hims’ March decision to stop advertising compounded GLP-1 drugs and expand branded offerings through Novo Nordisk. The company acquired a California peptide facility last year to bolster supply.
NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

16 April 2026
NuScale Power shares jumped to $13.23 before falling back to $11.52 Thursday after the White House ordered NASA to start a space-reactor program and Energy Secretary Chris Wright said initial U.S. reactors would likely get federal loans. NuScale remains the only U.S. firm with an approved small modular reactor design but has yet to secure firm orders or financing.
SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

16 April 2026
SoFi Technologies shares rose 1.5% Thursday after launching instant bank transfers via its Galileo platform, allowing money to move between SoFi and outside banks in seconds. The stock traded near $19.08 in New York. Investors await first-quarter results April 29, with SoFi guiding to $1.04 billion in adjusted net revenue and 12 cents per share in adjusted earnings.
D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

16 April 2026
D-Wave Quantum shares climbed about 5% Thursday, extending a 22.6% surge after Nvidia launched Ising, a new AI model family for quantum computing. D-Wave traded at $21.81, up from last year’s lows, and reported 2025 revenue of $24.6 million with first-quarter 2026 bookings topping $32.8 million. The company completed its $250 million Quantum Circuits acquisition in January. Market cap stood near $8.4 billion.
Morgan Stanley stock slides as AI tax tool spooks wealth managers
Previous Story

Morgan Stanley stock slides as AI tax tool spooks wealth managers

London Stock Exchange Group (LSEG) share price jumps on Elliott stake report as buyback debate flares up
Next Story

London Stock Exchange Group (LSEG) share price jumps on Elliott stake report as buyback debate flares up

Go toTop